Financial report interval: 2025.12.31 - 2026.03.31
Overview: Fuan Pharmaceutical(300194) the Revenue is 407.49 M (-12.87%);the EBIT is 35.38 M (-20.39%);the EPS is 0.05 (-16.67%).